Hailiang Li
Key Laboratory Of Craniocerebral Diseases
Yinchuan, China
Yinchuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Metformin upregulates circadian gene PER2 to inhibit growth and enhance the sensitivity of glioblastoma cell lines to radiotherapy via SIRT2/G6PD pathway.
Journal: Frontiers in pharmacology
Published: January 20, 2025
Wearing individualized 3D printed oral stent to protect normal tissues in patients with nasopharyngeal carcinoma during radiotherapy.
Journal: Journal of applied clinical medical physics
Published: June 07, 2023
Integrated transcriptomic and metabolomic profiling reveals dysregulation of purine metabolism during the acute phase of spinal cord injury in rats.
Journal: Frontiers in neuroscience
Published: October 11, 2022
Microglial activation in the motor cortex mediated NLRP3-related neuroinflammation and neuronal damage following spinal cord injury.
Journal: Frontiers in cellular neuroscience
Published: May 29, 2022
Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation.
Journal: Bioengineered
Published: May 23, 2022
Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder.
Journal: Frontiers in pharmacology
Published: November 22, 2021
Hippocampal Mitochondrial Abnormalities Induced the Dendritic Complexity Reduction and Cognitive Decline in a Rat Model of Spinal Cord Injury.
Journal: Oxidative medicine and cellular longevity
Published: November 04, 2021
Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Reinstatement of Cocaine-Mediated Conditioned Place Preference in Mice.
Journal: Frontiers in behavioral neuroscience
Published: September 02, 2021
Glucagon-Like Peptide-1 Agonist Exendin-4 Facilitates the Extinction of Cocaine-Induced Condition Place Preference.
Journal: Frontiers in systems neuroscience
Published: May 19, 2021
IAP-1 promoted cisplatin resistance in nasopharyngeal carcinoma via inhibition of caspase-3-mediated apoptosis.
Journal: American journal of cancer research
Published: September 18, 2020
The circadian clock gene PER2 enhances chemotherapeutic efficacy in nasopharyngeal carcinoma when combined with a targeted nanosystem.
Journal: Journal of materials chemistry. B
Published: May 28, 2020
TAT peptide-modified cisplatin-loaded iron oxide nanoparticles for reversing cisplatin-resistant nasopharyngeal carcinoma.
Journal: Biochemical and biophysical research communications
Published: February 18, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026